Innate immune responses in central nervous system inflammation (Q37882071)

24 August 2017

1 reference

title

Innate immune responses in central nervous system inflammation (English)

1 reference

24 August 2017

0 references

0 references

Bente Finsen

1

0 references

Trevor Owens

object named as

Trevor Owens

2

0 references

language of work or name

English

0 references

publication date

27 May 2011

1 reference

full work available at URL

24 August 2017

https://doi.org/10.1016/j.febslet.2011.05.030

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21624366

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1016%2Fj.febslet.2011.05.030

3 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2011.05.030

https://febs.onlinelibrary.wiley.com/doi/pdf/10.1016/j.febslet.2011.05.030

3 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2011.05.030

3 December 2024

1 reference

24 August 2017

volume

585

1 reference

24 August 2017

issue

23

1 reference

24 August 2017

page(s)

3806-3812

1 reference

Multiple sclerosis: a complicated picture of autoimmunity.

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.05.030

Autoimmune T cell responses in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.05.030

Perivascular spaces and the two steps to neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.05.030

Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.05.030

Inhibition of reactive astrocytosis in established experimental autoimmune encephalomyelitis favors infiltration by myeloid cells over T cells and enhances severity of disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.05.030

Experimental autoimmune encephalomyelitis repressed by microglial paralysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.05.030

Microglia: active sensor and versatile effector cells in the normal and pathologic brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.05.030

Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.05.030

Role of the innate immune system in the pathogenesis of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.05.030

Neutralising antibodies to interferon beta in multiple sclerosis : expert panel report

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.05.030

Distinct and Nonredundant In Vivo Functions of IFNAR on Myeloid Cells Limit Autoimmunity in the Central Nervous System

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.05.030

T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.05.030

Injury-induced type I IFN signaling regulates inflammatory responses in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.05.030

Type I interferon in organ-targeted autoimmune and inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.05.030

Differential regulation of interferon regulatory factor (IRF)-7 and IRF-9 gene expression in the central nervous system during viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.05.030

The potential role of dendritic cells in immune-mediated inflammatory diseases in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.05.030

Regional CNS responses to IFN-gamma determine lesion localization patterns during EAE pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.05.030

Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.05.030

The central nervous system environment controls effector CD4+ T cell cytokine profile in experimental allergic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.05.030

Microglial recruitment, activation, and proliferation in response to primary demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.05.030

Inflammation in the central nervous system and Th17 responses are inhibited by IFN-gamma-Induced IL-18 binding protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.05.030

Caspase-1-processed cytokines IL-1beta and IL-18 promote IL-17 production by gammadelta and CD4 T cells that mediate autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.05.030

The contribution of gammadelta T cells to the pathogenesis of EAE and MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.05.030

Inhibition of astroglial nuclear factor kappaB reduces inflammation and improves functional recovery after spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.05.030

Brain angiotensin II: new developments, unanswered questions and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.05.030

Angiotensin II controls occludin function and is required for blood brain barrier maintenance: relevance to multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.05.030

Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1- and TH17-mediated autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.05.030

Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.05.030

Macrophage polarization comes of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.05.030

Enhanced microglial clearance of myelin debris in T cell-infiltrated central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.05.030

Toll-like receptor 2 signaling in response to brain injury: an innate bridge to neuroinflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.05.030

Debris clearance by microglia: an essential link between degeneration and regeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.05.030

Remyelination in the CNS: from biology to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.05.030

Axonal plasticity elicits long-term changes in oligodendroglia and myelinated fibers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.05.030

Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2011.05.030

Inflammation, demyelination, and degeneration - recent insights from MS pathology.

21 January 2018

2

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2011.05.030

Toll-like receptors in neurodegeneration.

3 December 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2011.05.030

Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll-like receptor-mediated neuronal injury

3 December 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2011.05.030

IFN-beta gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis.

3 December 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2011.05.030

Interferon-beta is a key regulator of proinflammatory events in experimental autoimmune encephalomyelitis

3 December 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2011.05.030

Interleukin 18-independent engagement of interleukin 18 receptor-alpha is required for autoimmune inflammation

3 December 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2011.05.030

NF-kappaB-driven STAT2 and CCL2 expression in astrocytes in response to brain injury

3 December 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2011.05.030

Angiotensin II Type 1 receptor (AT1) signaling in astrocytes regulates synaptic degeneration-induced leukocyte entry to the central nervous system.

3 December 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2011.05.030

Axotomy-induced glial reactions in normal and cytokine transgenic mice.

3 December 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2011.05.030

Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS.

3 December 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2011.05.030

Axonal degeneration stimulates the formation of NG2+ cells and oligodendrocytes in the mouse

3 December 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.FEBSLET.2011.05.030

3 December 2024

Identifiers

1 reference

24 August 2017

1 reference